Načítá se...
Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19
Coronavirus disease 2019 (COVID-19) is a global health emergency caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The rapid worldwide spread of SARS-CoV-2 infection has necessitated a global effort to identify effective therapeutic strategies in the absence of vaccine. Among t...
Uloženo v:
| Vydáno v: | Cell Immunol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7558230/ https://ncbi.nlm.nih.gov/pubmed/33137649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2020.104240 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|